World's Best Scientists 2026 revealed!
Peter A. Cohen

Peter A. Cohen

D-Index & Metrics

Immunology

D-Index
51
Citations
11082
World Ranking
4133
National Ranking
1885

Overview

Peter A. Cohen is affiliated with the Mayo Clinic in the United States. Their research spans multiple interdisciplinary fields, with a core focus on social sciences as well as biomedical and molecular biology topics.

Their work includes contributions to the following main topics:

  • CAR-T cell therapy research
  • Graphene and Nanomaterials Applications
  • RNA Interference and Gene Delivery
  • Urban, Neighborhood, and Segregation Studies
  • Youth Substance Use and School Attendance
  • School Choice and Performance

They have contributed to several fields of study, notably:

  • Social Sciences

Within these broader fields, their subfields of study include:

  • Education
  • Oncology
  • Biomedical Engineering
  • Molecular Biology
  • Sociology and Political Science

Peter A. Cohen has published papers in the following venues:

  • Oncotarget
  • SSRN Electronic Journal

Some of their recent publications include:

  • "Multipeptide stimulated PBMCs generate TEM/TCM for adoptive cell therapy in multiple myeloma," published in 2021 in Oncotarget
  • "Punished for Leaving? Student Mobility, Suspensions, and the Moderating Role of School Context," published in 2025 in SSRN Electronic Journal

The scientist has frequently collaborated with other researchers including:

  • Trupti Vardam-Kaur
  • Latha Pathangey
  • Daniel McCormick
  • P. Leif Bergsagel
  • Sandra Gendler

Best Publications

  • Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species

    Eugene A. Podrez;Maria Febbraio;Nader Sheibani;David Schmitt

  • Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

    Vani Lakshminarayanan;Pamela Thompson;Margreet A. Wolfert;Therese Buskas

  • Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained

    Jennifer S. Ko;Patricia Rayman;Joanna Ireland;Shadi Swaidani

  • MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.

    James Finke;Jennifer Ko;Brian Rini;Pat Rayman

  • Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.

    Brian J. Czerniecki;Gary K. Koski;Gary K. Koski;Ursula Koldovsky;Shuwen Xu

  • Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma

    Thinle Chodon;Thinle Chodon;Begonya Comin-Anduix;Bartosz Chmielowski;Richard C Koya;Richard C Koya

  • Formation of Nitric Oxide–Derived Oxidants by Myeloperoxidase in Monocytes: Pathways for Monocyte-Mediated Protein Nitration and Lipid Peroxidation In Vivo

    Stanley L. Hazen;Renliang Zhang;Zhongzhou Shen;Weijia Wu

  • Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells.

    Brian J. Czerniecki;Brian J. Czerniecki;Charles Carter;Licia Rivoltini;Gary K. Koski

  • Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8+ T-Cell Function in Melanoma Patients

    Isabelle Bedrosian;Rosemarie Mick;Shuwen Xu;Harvey Nisenbaum

  • Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells

    Gary K. Koski;Katalin Karikó;Shuwen Xu;Drew Weissman

  • Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells.

    Philip J. Cohen;Peter A. Cohen;Steven A. Rosenberg;James J. Mulé

  • Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment.

    Daniel H. Fowler;Kazuhiro Kurasawa;Anne Husebekk;Peter A Cohen

  • Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependent Mechanism

    Shuwen Xu;Gary K. Koski;Mark Faries;Isabelle Bedrosian

  • CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection.

    Peter A. Cohen;Liaomin Peng;Gregory E. Plautz;Julian A. Kim

  • Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes.

    Satoshi Watanabe;Katsuya Deguchi;Rongxiu Zheng;Hidemasa Tamai

  • T cell adoptive immunotherapy of newly diagnosed gliomas.

    Gregory E. Plautz;David W. Miller;Gene H. Barnett;Glen H. J. Stevens

  • Bacterial Lipopolysaccharide, TNF-α, and Calcium Ionophore Under Serum-Free Conditions Promote Rapid Dendritic Cell-Like Differentiation in CD14+ Monocytes Through Distinct Pathways That Activate NF-κB

    Lyudmila A. Lyakh;Gary K. Koski;William Telford;Ronald E. Gress

  • Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination

    Anamika Bose;Jennifer L. Taylor;Sean Alber;Simon C. Watkins

  • Detection of occult follicular lymphoma by specific DNA amplification.

    M Stetlet-Stevenson;M Raffeld;P Cohen;J Cossman

  • Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor

    Jørgen Kjaergaard;Liaomin Peng;Peter A. Cohen;Judith A. Drazba

Frequent Co-Authors

Suyu Shu
Suyu Shu University of Michigan–Ann Arbor
James H. Finke
James H. Finke Cleveland Clinic Lerner College of Medicine
Steven A. Rosenberg
Steven A. Rosenberg National Institutes of Health
Geert-Jan Boons
Geert-Jan Boons University of Georgia
Margreet A. Wolfert
Margreet A. Wolfert Utrecht University
Walter J. Storkus
Walter J. Storkus University of Pittsburgh
Brian I. Rini
Brian I. Rini Vanderbilt University Medical Center
Ronald E. Gress
Ronald E. Gress National Institutes of Health
James J. Mulé
James J. Mulé University of South Florida

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with healthcare roles that emphasize patient care, research, and clinical support. For those interested in expanding their qualifications or transitioning into healthcare, there are several accessible educational pathways. For example, many students choose online nursing programs for non nurses to gain foundational knowledge and clinical skills without prior healthcare experience.

For aspiring nurses, enrolling in easiest absn programs to get into can fast-track the journey toward becoming a registered nurse. These accelerated programs are designed to accommodate students with degrees in other fields, offering a quicker path to licensure.

Alternatively, those looking for less competitive entry points might consider easy admission lpn programs, which provide practical nursing credentials and valuable hands-on experience in patient care roles.

For advanced clinical practice, easy nurse practitioner programs to get into offer a way to specialize further while benefiting from relatively accessible admissions. Such pathways complement immunology-related careers by enhancing patient management skills in specialized healthcare settings.

Best Scientists Citing Peter A. Cohen

Trending Scientists

Recently Published Articles